Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation

P Zhang, D Wang, Y Zhao, S Ren, K Gao, Z Ye… - Nature medicine, 2017 - nature.com
Bromodomain and extraterminal domain (BET) protein inhibitors are emerging as promising
anticancer therapies. The gene encoding the E3 ubiquitin ligase substrate-binding adaptor …

Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation

P Zhang, D Wang, Y Zhao, S Ren, K Gao… - Nature …, 2017 - pubmed.ncbi.nlm.nih.gov
Bromodomain and extraterminal domain (BET) protein inhibitors are emerging as promising
anticancer therapies. The gene encoding the E3 ubiquitin ligase substrate-binding adaptor …

Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation

P Zhang, D Wang, Y Zhao, S Ren, K Gao, Z Ye… - Nature Medicine, 2017 - go.gale.com
Bromodomain and extraterminal domain (BET) protein inhibitors are emerging as promising
anticancer therapies. The gene encoding the E3 ubiquitin ligase substrate-binding adaptor …

[CITATION][C] Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation

P Zhang, D Wang, Y Zhao, S Ren, K Gao, Z Ye… - Nature Medicine, 2017 - cir.nii.ac.jp
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET
protein stabilization and AKT–mTORC1 activation | CiNii Research CiNii 国立情報学研究所 …

Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation

P Zhang, D Wang, Y Zhao, S Ren… - Nature …, 2017 - mayoclinic.elsevierpure.com
Bromodomain and extraterminal domain (BET) protein inhibitors are emerging as promising
anticancer therapies. The gene encoding the E3 ubiquitin ligase substrate-binding adaptor …

Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation

P Zhang, D Wang, Y Zhao, S Ren, K Gao… - Nature …, 2017 - scholars.uthscsa.edu
Bromodomain and extraterminal domain (BET) protein inhibitors are emerging as promising
anticancer therapies. The gene encoding the E3 ubiquitin ligase substrate-binding adaptor …

[PDF][PDF] Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation

P Zhang, D Wang, Y Zhao, S Ren, K Gao, Z Ye… - Nature …, 2017 - drive.google.com
Bromodomain and extraterminal domain (BET) protein inhibitors are emerging as promising
anticancer therapies. The gene encoding the E3 ubiquitin ligase substrate-binding adaptor …

Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation

P Zhang, D Wang, Y Zhao, S Ren, K Gao, Z Ye… - Nature …, 2017 - hero.epa.gov
Bromodomain and extraterminal domain (BET) protein inhibitors are emerging as promising
anticancer therapies. The gene encoding the E3 ubiquitin ligase substrate-binding adaptor …

Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.

P Zhang, D Wang, Y Zhao, S Ren, K Gao, Z Ye… - Nature …, 2017 - europepmc.org
Bromodomain and extraterminal domain (BET) protein inhibitors are emerging as promising
anti-cancer therapies. The gene encoding the E3 ubiquitin ligase substrate-binding adaptor …

Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.

P Zhang, D Wang, Y Zhao, S Ren, K Gao, Z Ye… - Nature …, 2017 - europepmc.org
Bromodomain and extraterminal domain (BET) protein inhibitors are emerging as promising
anti-cancer therapies. The gene encoding the E3 ubiquitin ligase substrate-binding adaptor …